Evidence map›Paper›PMID 33593854›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2021

Interleukin-4 Induces the Release of Opioid Peptides from M1 Macrophages in Pathological Pain.

Dominika Labuz, Melih Ö Celik, Viola Seitz, Halina Machelska

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Emerging role of macrophages in neuropathic pain.Journal of orthopaedic translation · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. HDAC6 Inhibition Reverses Cisplatin-Induced Mechanical Hypersensitivity via Tonic Delta Opioid Receptor Signaling.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  19. Article
  20. Burning and Scaling Probably Associated with Dupilumab Therapy: A Case Report.Clinical, cosmetic and investigational dermatology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dominika LabuzDepartment of Experimental Anesthesiology, Charité-Universitätsmedizin Berlin, Berlin 12203, Germany.ORCID 0000-0003-2465-4730
Melih Ö CelikDepartment of Experimental Anesthesiology, Charité-Universitätsmedizin Berlin, Berlin 12203, Germany hmachelska@gmail.com ozgur.celik@charite.de.ORCID 0000-0002-7706-4964
Viola SeitzDepartment of Experimental Anesthesiology, Charité-Universitätsmedizin Berlin, Berlin 12203, Germany.ORCID 0000-0002-8086-8090
Halina MachelskaDepartment of Experimental Anesthesiology, Charité-Universitätsmedizin Berlin, Berlin 12203, Germany hmachelska@gmail.com ozgur.celik@charite.de.ORCID 0000-0001-6315-2958
Charité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-4 (IL-4) is an anti-inflammatory cytokine, which can be protective in inflammatory and neurologic disorders, and can alleviate pain. Classically, IL-4 diminishes pain by blocking the production of proinflammatory cytokines. Here, we uncovered that IL-4 induces acute antinociception by IL-4 receptor α (IL-4Rα)-dependent release of opioid peptides from M1 macrophages at injured nerves. As a model of pathologic pain, we used a chronic constriction injury (CCI) of the sciatic nerve in male mice. A single application of IL-4 at the injured nerves (14 d following CCI) attenuated mechanical hypersensitivity evaluated by von Frey filaments, which was reversed by co-injected antibody to IL-4Rα, antibodies to opioid peptides such as Met-enkephalin (ENK), β-endorphin and dynorphin A 1-17, and selective antagonists of δ-opioid, µ-opioid, and κ-opioid receptors. Injured nerves were predominately infiltrated by proinflammatory M1 macrophages and IL-4 did not change their numbers or the phenotype, assessed by flow cytometry and qRT-PCR, respectively. Macrophages isolated from damaged nerves by immunomagnetic separation (IMS) and stimulated with IL-4 dose dependently secreted all three opioid peptides measured by immunoassays. The IL-4-induced release of ENK was diminished by IL-4Rα antibody, intracellular Ca

Indexed as

AnimalsInterleukin-4Interleukin-4 Receptor alpha SubunitMacrophagesMaleMiceMice, Inbred C57BLNarcotic AntagonistsNeuralgiaOpioid PeptidesPain MeasurementReceptors, Cell SurfaceSciatic NeuropathyIl4ra protein, mouseInterleukin-4Interleukin-4 Receptor alpha SubunitNarcotic AntagonistsOpioid PeptidesReceptors, Cell Surfaceanalgesiaantinociceptioncalcium-mediated releaseneuropathic painopioidsperipheral opioid receptors

Identifiers

PMID33593854
PMCPMC8018889
OpenAlexW3131349085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.